Correlation Between Monopar Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Monopar Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Monopar Therapeutics and Eliem Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monopar and Eliem is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 5.0 times more return on investment than Eliem Therapeutics. However, Monopar Therapeutics is 5.0 times more volatile than Eliem Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 485.00 in Monopar Therapeutics on August 26, 2024 and sell it today you would earn a total of 1,525 from holding Monopar Therapeutics or generate 314.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.75% |
| Values | Daily Returns |
Monopar Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Monopar Therapeutics |
| Eliem Therapeutics |
Monopar Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Monopar Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |